Table 1 Demographic information of patients
From: TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients
Parameters | Patients group (%) |
|---|---|
Age (years) | |
< 50 | 57.5 |
≥ 50 | 42.5 |
Race | |
Persian | 22.5 |
Turk | 30 |
Gilaki and Mazani | 10 |
Kurd | 12.5 |
Lor | 7.5 |
N/A | 17.5 |
Histology grade | |
Grade I (low-well differentiated) | 17.5 |
Grade II (intermediate-moderately differentiated) | 47.5 |
Grade III (high-poor differentiated) | 35 |
Stage | |
II | 72.5 |
III | 27.5 |
Necrosis | |
Yes | 65 |
No | 35 |
Vascular/lymphatic invasion | |
Positive | 62.5 |
Negative | 37.5 |
Perineural invasion | |
Yes | 30 |
No | 70 |